Squarepoint’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$788K Buy
148,335
+68,208
+85% +$362K ﹤0.01% 1657
2025
Q1
$711K Sell
80,127
-58,742
-42% -$521K ﹤0.01% 1700
2024
Q4
$1.9M Buy
138,869
+29,524
+27% +$405K ﹤0.01% 1194
2024
Q3
$2.99M Buy
109,345
+82,059
+301% +$2.25M ﹤0.01% 953
2024
Q2
$667K Sell
27,286
-59,290
-68% -$1.45M ﹤0.01% 1582
2024
Q1
$1.85M Buy
86,576
+45,572
+111% +$972K ﹤0.01% 1069
2023
Q4
$785K Buy
41,004
+16,265
+66% +$311K ﹤0.01% 1474
2023
Q3
$397K Buy
24,739
+9,598
+63% +$154K ﹤0.01% 1758
2023
Q2
$351K Sell
15,141
-11,518
-43% -$267K ﹤0.01% 1785
2023
Q1
$619K Sell
26,659
-139,725
-84% -$3.25M ﹤0.01% 1376
2022
Q4
$2.41M Buy
166,384
+140,496
+543% +$2.04M 0.01% 708
2022
Q3
$494K Buy
+25,888
New +$494K ﹤0.01% 1413
2020
Q4
Sell
-35,862
Closed -$468K 2763
2020
Q3
$468K Sell
35,862
-51,191
-59% -$668K 0.01% 1393
2020
Q2
$987K Buy
+87,053
New +$987K 0.02% 941
2019
Q4
Sell
-7,700
Closed -$220K 2571
2019
Q3
$220K Sell
7,700
-65,938
-90% -$1.88M ﹤0.01% 1946
2019
Q2
$2.05M Buy
+73,638
New +$2.05M 0.02% 821
2019
Q1
Sell
-19,235
Closed -$559K 2285
2018
Q4
$559K Buy
19,235
+2,596
+16% +$75.4K 0.01% 1174
2018
Q3
$765K Buy
+16,639
New +$765K 0.01% 1111
2018
Q2
Sell
-42,560
Closed -$1.26M 1939
2018
Q1
$1.26M Buy
42,560
+17,544
+70% +$519K 0.02% 716
2017
Q4
$859K Sell
25,016
-27,316
-52% -$938K 0.02% 891
2017
Q3
$1.89M Sell
52,332
-2,919
-5% -$106K 0.04% 510
2017
Q2
$1.43M Buy
+55,251
New +$1.43M 0.03% 606
2017
Q1
Sell
-44,638
Closed -$744K 1770
2016
Q4
$744K Buy
+44,638
New +$744K 0.03% 622
2016
Q3
Sell
-13,680
Closed -$419K 1172
2016
Q2
$419K Sell
13,680
-7,420
-35% -$227K 0.03% 616
2016
Q1
$790K Buy
21,100
+14,300
+210% +$535K 0.06% 450
2015
Q4
$293K Buy
+6,800
New +$293K 0.03% 801